Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-32,609
Closed -$243K 3612
2023
Q1
$243K Hold
32,609
﹤0.01% 3127
2022
Q4
$404K Buy
32,609
+859
+3% +$15.1K ﹤0.01% 3054
2022
Q3
$655K Buy
31,750
+503
+2% +$14K ﹤0.01% 2920
2022
Q2
$866K Buy
31,247
+5,408
+21% +$185K ﹤0.01% 2845
2022
Q1
$1.13M Sell
25,839
-7,574
-23% -$329K ﹤0.01% 2806
2021
Q4
$1.84M Buy
33,413
+489
+1% +$30.2K ﹤0.01% 2729
2021
Q3
$2.04M Sell
32,924
-4,640
-12% -$305K ﹤0.01% 2702
2021
Q2
$3.19M Buy
37,564
+725
+2% +$66.1K ﹤0.01% 2562
2021
Q1
$2.91M Buy
36,839
+6,334
+21% +$411K ﹤0.01% 2544
2020
Q4
$1.78M Buy
30,505
+860
+3% +$40.5K ﹤0.01% 2623
2020
Q3
$1M Sell
29,645
-4,558
-13% -$173K ﹤0.01% 2676
2020
Q2
$1.58M Buy
34,203
+476
+1% +$13.2K ﹤0.01% 2494
2020
Q1
$533K Hold
33,727
﹤0.01% 2691
2019
Q4
$925K Buy
33,727
+3,093
+10% +$82.7K ﹤0.01% 2625
2019
Q3
$901K Buy
30,634
+18,095
+144% +$538K ﹤0.01% 2605
2019
Q2
$360K Buy
+12,539
New +$422K ﹤0.01% 2956
2016
Q2
Sell
-2,211
Closed -$83K 3106
2016
Q1
$83K Hold
2,211
﹤0.01% 3002
2015
Q4
$158K Hold
2,211
﹤0.01% 3000
2015
Q3
$137K Hold
2,211
﹤0.01% 3006
2015
Q2
$298K Buy
+2,211
New +$212K ﹤0.01% 2882

Other funds holding AFMD

Charles Schwab's AFMD Position: Q2 2023 in Review

Charles Schwab sold out of Affimed (AFMD) in Q2 2023, closing a stake of 32,609 shares — an estimated $243K sold.

Charles Schwab first reported a position in AFMD in Q2 2015 and held it in 20 quarters. The position peaked at $3.19M in Q2 2021. 80 funds tracked by Wall St. Rank hold AFMD as of Q2 2023.

  • Charles Schwab reported no remaining Affimed position as of Q2 2023 after selling out during the quarter.
  • Charles Schwab sold 32,609 Affimed shares in Q2 2023, an estimated $243K.
  • Charles Schwab first reported a position in Affimed in Q2 2015 and held it in 20 quarters.
  • Charles Schwab's Affimed position peaked at $3.19M in Q2 2021.
  • 80 funds tracked by Wall St. Rank held Affimed as of Q2 2023.

Based on Charles Schwab's 13F filing for Q2 2023, filed 10 Aug 2023.